Research and News Involving:
Oncology
Adult, CureAccelerator Live!, Current Research, Dr. Fleischman, Drug, Oncology, Rare Disease, University of California, University of California Irvine
Treating a Group of Rare Blood Cancers, Myeloproliferative Neoplasms, with N-Acetylcysteine Principal Investigator: Dr. Angela Fleischman Disease: Myeloproliferative neoplasms: Polycythemia vera, essential thrombocythemia and myelofibrosis Research Description:...
Completed Research, Dr. Riggins, Drug, Johns Hopkins Medicine, Mid-Atlantic, Oncology, Pediatric, Rare Disease
A Phase I Trial for Recurrent Pediatric Brain Cancers Using a Repurposed Generic Drug Principal Investigator: Dr. Gregory Riggins Disease: Medulloblastoma, Glioblastoma Research Description: Medulloblastoma is the most common malignant brain tumor in children, and...
Adult, Completed Research, Device, Dr. Davalos, Dr. Martin, Mid-Atlantic, Oncology, Rare Disease, Virginia Tech University
Using an Approved Device to Increase the Immune Response in Pancreatic Cancer Patients Principal Investigator: Dr. Rafael Davalos Co-Investigator: Dr. Robert C.G. Martin Disease: Pancreatic Cancer Research Description: Irreversible electroporation (IRE) is a...
Completed Research, Dr. Leary, Drug, Oncology, Pediatric, Rare Disease, Seattle Children's
Repurposing Drugs for Recurrent Pediatric Brain Tumors Principal Investigator: Dr. Sarah Leary Disease: Pediatric Brain Cancer Research Description: Pediatric brain tumors are the most common solid tumor malignancy in children, and continue to be a leading cause of...
Adult, Chicago, Completed Research, Diagnostic, Dr. Borgia, Oncology, Rush University Medical Center
Repurposing a blood test to improve outcomes for high-risk lung cancer patients undergoing low-dose CT screening Principal Investigator: Dr. Jeffrey Borgia Disease: Lung Cancer Research Description: Early detection of lung cancer can save lives. Low‐dose computer...
Adult, Completed Research, CureAccelerator Live!, Dr. Swiecicki, Drug, Longest Day of Golf, Oncology, Rare Disease, University of Michigan
Repurposing Old Drugs as New Therapies for Metastatic Thyroid Cancer Principal Investigator: Dr. Paul Swiecicki Disease: Thyroid Cancer Research Description: Thyroid cancer is the sixteenth most common malignancy in the world. Although most patients are cured with a...
Adult, Dr. Pettit, Drug, Oncology, Rare Disease, University of Michigan
Using a Skin Cancer Drug to Improve Current Treatment in a Rare Blood Cancer, Myelofibrosis Principal Investigator: Dr. Kristen Pettit Disease: Myelofibrosis Research Description: Myelofibrosis (MF) is a rare, aggressive bone marrow cancer causing excessive scar...
Adult, Combo, Completed Research, Dr. Halatsch, Drug, Neuro, Oncology, Rare Disease, Ulm University
Combining Nine Repurposed Drugs with a Current Chemotherapy Treatment in Adult Brain Cancer Principal Investigator: Dr. Marc-Eric Halatsch Disease: Glioblastoma Research Description: For decades, new experimental therapies have repeatedly failed to improve the...
Adult, Completed Research, CureAccelerator Live!, Dr. Arrillaga-Romany, Dr. Kouwenhoven, Dr. Tannous, Dr. Van Linde, Drug, Harvard Medical School, Longest Day of Golf, Massachusetts General Hospital, Neuro, Oncology, Rare Disease, VUmc Cancer Center Amsterdam
A Novel Combination of Generic Chemotherapy Drugs to Treat Brain Cancer Principal Investigators: Dr. Bakhos Tannous, Dr. Isabel Arrillaga-Romany, Dr. Mathilde Kouwenhoven, Dr. Myra Van Linde Disease: Glioblastoma Research Description: Glioblastomas (GBMs) are...
Adult, Chicago, Completed Research, Dr. Bestvina, Dr. Chmura, Drug, Oncology, University of Chicago
Innovations in Combination Therapies for Non-Small Cell Lung Cancer Principal Investigator: Dr. Steve Chmura and Dr. Christine Bestvina Disease: Non-Small Cell Lung Cancer Research Description: Lung cancer is the most deadly cancer in the U.S. for both men and women,...
